For National Women’s Health Week, One Company Emphasizes Cardiovascular Risk Management

May 10th 2022, 10:30pm


On this episode of Managed Care Cast, we speak with Joanne Armstrong, MD, MPH, vice president and chief medical officer for Women’s Health and Genomics at CVS Health, on the distinct pathophysiology of cardiovascular disease in women and how her own health experiences have influenced her perspective on cardiovascular disease management.

What Does a Multidisciplinary Team Look Like?

May 10th 2022, 3:02pm


Drs Brinton and Slipczuk go into detail regarding an ideal multidisciplinary team for ASCVD treatment.

Defining “Optimal Care” for ASCVD Within Health Systems

May 10th 2022, 2:58pm


Drs Riddock and Slipczuk define “optimal care” for ASCVD from a system-level perspective with the use of quality metrics.

Unmet Needs in Lipid Management

May 3rd 2022, 4:27pm


Dr Eliot Brinton elaborates on unmet needs in lipid management and how they can be remedied.

Ensuring Continuity of Care for the ASCVD Patient

May 3rd 2022, 4:21pm


Ian Riddock, MD, and Leandro N. Slipczuk, MD, PhD, discuss the importance of LDL-C management as part of the discharge plan for patients, as well as ensuring continuity of care from the inpatient to outpatient setting.

Using Adjunct Therapies in LDL Management

April 26th 2022, 4:49pm


Dr Brinton highlights the importance of adjunct therapies in LDL management.

Therapy Beyond Statins in the Inpatient Setting

April 26th 2022, 4:39pm


Dr Riddock explains how the ASCVD treatment landscape lends itself to initiation of therapy beyond statins in the inpatient setting.

Finding the Optimal Statin Dose

April 20th 2022, 4:43pm


Eliot Brinton, MD, provides a warning concerning “maximally-tolerated statin dosing” and provides general guidance for optimal dosing.

Who is an Ideal Patient for Early Intensive Lipid Lowering?

April 20th 2022, 4:35pm


Ian Riddock, MD, describes the high-risk patient with ASCVD that is appropriate for early intensive lipid lowering.

Residual Cardiovascular Risk

April 8th 2022, 5:36pm


Ian Riddock, MD, describes residual cardiovascular risk, both with and without the use of statin therapies.